Skip to main content
search
All Posts By

Ben Kemp

HighlightsHighlights Archive

Media Monitoring: 6 – 11 June

Major cause of Inflammatory Bowel Disease discovered A groundbreaking piece of research has been published this week that could lead to greater understanding of Crohn’s and Colitis and possibly new treatments in the future. Using genetic analysis, the researchers found a section of genetic code (DNA) that is active in macrophages. Macrophages are a type of immune cell that cause…
Ben Kemp
June 11, 2024
HighlightsHighlights Archive

New flu biomarkers discovery could lead to personalised vaccine schedules

Researchers have identified new biomarkers that could enable personalised flu vaccination schedules, ensuring longer-lasting immunity. The findings were presented at the European Society of Human Genetics meeting and involves classifying individual immune responses to predict who may not be adequately protected by standard flu vaccines. By using multiomics technology, the study analysed blood samples to identify predictive markers, aiming to…
Ben Kemp
June 11, 2024
HighlightsHighlights Archive

New AI tool quickly rules out heart attacks in A&E patients

A new AI tool developed in the UK, named Rapid-RO, can quickly rule out heart attacks in A&E patients, potentially reducing unnecessary hospital stays. During trials, it accurately ruled out heart attacks in over a third of patients, outperforming traditional troponin blood tests. Patients often require multiple troponin tests during their stay, however, Rapid-RO requires just one. The AI uses…
Ben Kemp
June 11, 2024
Uncategorized

Election Health Roundup

The last few days has seen the release of both the Conservatives' and Lib Dems' manifestos, containing key pledges on health and life sciences. Conservatives The Conservative Party's manifesto, released on Tuesday, has specifically promised improvements for diagnostics in the NHS. The party has pledged to invest £3.4 billion in new diagnostic technology, roll out new digital health checks to…
Ben Kemp
June 11, 2024
Membership NewsMembership News Archive

Supply your products to ReMed Conference 2024

Professor Rahimifard, Professor of Sustainable Engineering at Loughborough University, will be a guest speaker at the Environmental Working Party in September and will be talking about the ReMed, a collaboration between Leeds and Loughborough Universities. He would like to ask whether any members be willing to forward a small sample of in vitro diagnostics products to to the RedMed conference.…
Ben Kemp
June 11, 2024
Membership NewsMembership News Archive

Get a 20% discount on BS EN ISO 20916

  BSI has recently launched BS EN ISO 20916. The standard defines good practice for clinical performance studies of IVD medical devices. BIVDA members can get a 20% discount on this standard by entering SHOBVIDA20 at the checkout. BS EN ISO 20916 It’s critical that clinical performance studies consistently produce data of the highest quality so that safe healthcare decisions…
Ben Kemp
June 11, 2024
Membership NewsMembership News Archive

BIVDA attend Health Innovation North Conference 2024

Formed from the four regional Health Innovation Networks (HINs), the Health Innovation North team held its first conference in Liverpool on 6th June. Pulling together senior leaders from across the NHS, stakeholders, entrepreneurs, and patient representatives, the conference looked to champion the role of innovation in improving health outcomes. BIVDA's Angela Douglas and Paul Fisher attended. Angela said “Having started…
Ben Kemp
June 11, 2024
HighlightsHighlights Archive

Media Monitoring: May 30 – June 5

An update on the ongoing NHS-Galleri trial Based on data from the first year of the three-year NHS-Galleri trial, NHS England has decided that it will wait to see final results, expected in 2026, before considering whether an NHS rollout of the Galleri multi cancer early detection test (the Multi Cancer Blood Test Programme, MCBT) should go ahead. Many successful…
Ben Kemp
June 5, 2024
HighlightsHighlights Archive

Blood test predicts return of breast cancer

A new type of blood test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research has shown. A team from The Institute of Cancer Research, London, used an ultra-sensitive liquid biopsy to detect the presence of tiny amounts of cancer DNA left in the body following treatment for early breast cancer.…
Ben Kemp
June 5, 2024
Close Menu